MED13

protein-coding

mediator complex subunit 13, the group of Mediator complex

Gene summary

This gene encodes a component of the mediator complex (also known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought to be required for the expression of almost all genes. The mediator complex is recruited by transcriptional activators or nuclear receptors to induce gene expression, possibly by interacting with RNA polymerase II and promoting the formation of a transcriptional pre-initiation complex. The product of this gene is proposed to form a sub-complex with MED12, cyclin C, and CDK8 that can negatively regulate transactivation by mediator. [provided by RefSeq, Jul 2008]

Previous symbols:
  • THRAP1

MANE transcript

NM_005121.3

Inheritance

AD

ClinVar variants

P:88U:513B:158

Top phenotype

Intellectual developmental disorder, autosomal dominant 61

gnomAD constraint

pLI —, LoF o/e 0

Max pathogenic AF

—

Genomic locus

chr17:61,942,605-62,065,278

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~122.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual developmental disorder 61DEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0032485

Submitter: Ambry Genetics

intellectual developmental disorder 61STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0032485

Submitter: G2P

intellectual developmental disorder 61STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0032485

Submitter: Labcorp Genetics (formerly Invitae)

intellectual developmental disorder 61STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0032485

Submitter: PanelApp Australia

syndromic intellectual disabilitySUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0000508

Submitter: Orphanet

complex neurodevelopmental disorderDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0100038

Submitter: ClinGen

*MED13* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2018 (Snijders Blok et al., PMID: 29740699). The disorder is characterised by global developmental delay apparent in infancy with mildly impaired intellectual development, expressive speech delay, behavioural abnormalities (including autism spectrum disorder or attention deficit-hyperactivity disorder), nonspecific dysmorphic features, obstipation, ocular anomalies, and poor overall growth (PMID: 29740699). Fourteen variants (nonsense, frameshift, missense and in-frame indel) that have been reported in 15 probands in five publications are included in this curation (PMIDs: 25363768, 28263302, 29740699, 33258286, 33931951). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is loss of function. In summary, there is definitive evidence supporting the relationship between *MED13* and autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 17, 2022 (SOP Version 9).

intellectual developmental disorder 61STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0032485

Submitter: Illumina

Clinical Genomic Database (CGD)

Intellectual developmental disorder, autosomal dominant 61AD

Manifestation: Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 29740699Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to MED13 variants in ClinVar

19 Conditions Cataloged
not providedTotal: 350
Inborn genetic diseasesTotal: 268
Intellectual developmental disorder 61Total: 138
MED13-related disorderTotal: 78
not specifiedTotal: 54
See casesTotal: 4
Autosomal dominant isolated somatotropin deficiencyTotal: 3
Neurodevelopmental disorderTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005121.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
51
clinvar
5
clinvar
61
missense
2
clinvar
16
clinvar
494
clinvar
95
clinvar
7
clinvar
614
nonsense
15
clinvar
8
clinvar
4
clinvar
27
start loss
0
frameshift
20
clinvar
17
clinvar
3
clinvar
40
splice donor/acceptor (+/-2bp)
6
clinvar
4
clinvar
7
clinvar
17
Total434551314612759

Highest pathogenic variant AF is 0.0000013790459

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 10 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005121.3RefSeqNP_005112.230MANE Select
ENST00000397786.7EnsemblENSP00000380888.230MANE Select
ENST00000583958.1EnsemblENSP00000464131.13Standard
ENST00000934727.1EnsemblENSP00000604786.129Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
med13bDanio rerio

Structure: cranial neural crest cell

Quality: mislocalised

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Thyroid hormone signaling pathway - Homo sapiens (human)
  • Developmental Biology
  • Gene expression (Transcription)
  • Generic Transcription Pathway
  • RNA Polymerase II Transcription

Biological Process

  • regulation of transcription by RNA polymerase II
  • transcription initiation from RNA polymerase II promoter
  • intracellular steroid hormone receptor signaling pathway
  • androgen receptor signaling pathway
  • cholesterol homeostasis

Molecular Function

  • transcription coregulator activity
  • transcription coactivator activity
  • nuclear receptor transcription coactivator activity
  • signaling receptor activity
  • vitamin D receptor binding

Cellular Component

  • nucleus
  • nucleoplasm
  • membrane
  • mediator complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000397786
Coding exons
30
Length
122678
Individuals with no LoFs
124782
Homozygous LoFs
0
Heterozygous LoFs
3
Defined
124785
p
0.0000120
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.628711.12e+30.7790.000055614195
Missense (PolyPhen)314529.750.592736708
Synonymous-1.384223881.090.00001914248
Loss of Function9.19098.40.000.000004921257

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000930.000093rare
European (Non-Finnish)0.00000890.0000088rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}.;

Recessive Scores

pRec
0.134

Intolerance Scores

LoFtool
0.0136
RVIS EVS
-1.43
RVIS percentile EVS
4.05

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.692

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.